These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12692115)

  • 1. No apparent association between NAT1 and NAT2 genotypes and risk of stomach cancer.
    Lan Q; Rothman N; Chow WH; Lissowska J; Doll MA; Xiao GH; Zatonski W; Hein DW
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):384-6. PubMed ID: 12692115
    [No Abstract]   [Full Text] [Related]  

  • 2. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.
    Varzim G; Monteiro E; Silva R; Pinheiro C; Lopes C
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):206-12. PubMed ID: 12037388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
    Cascorbi I; Roots I; Brockmöller J
    Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma.
    Katoh T; Boissy R; Nagata N; Kitagawa K; Kuroda Y; Itoh H; Kawamoto T; Bell DA
    Int J Cancer; 2000 Jan; 85(1):46-9. PubMed ID: 10585581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma.
    Boissy RJ; Watson MA; Umbach DM; Deakin M; Elder J; Strange RC; Bell DA
    Int J Cancer; 2000 Aug; 87(4):507-11. PubMed ID: 10918189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
    Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
    Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
    Henning S; Cascorbi I; Münchow B; Jahnke V; Roots I
    Pharmacogenetics; 1999 Feb; 9(1):103-11. PubMed ID: 10208649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study.
    Wang CY; Jones RF; Debiec-Rychter M; Soos G; Haas GP
    Anticancer Res; 2002; 22(6B):3529-35. PubMed ID: 12552951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk.
    Millikan RC; Pittman GS; Newman B; Tse CK; Selmin O; Rockhill B; Savitz D; Moorman PG; Bell DA
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):371-8. PubMed ID: 9610785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylamine N-acetyltransferase 1 (NAT1) genotypes in a Lebanese population.
    Dhaini HR; Levy GN
    Pharmacogenetics; 2000 Feb; 10(1):79-83. PubMed ID: 10739175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetyltransferase 1 genetic polymorphism influences the risk of prostate cancer development.
    Fukutome K; Watanabe M; Shiraishi T; Murata M; Uemura H; Kubota Y; Kawamura J; Ito H; Yatani R
    Cancer Lett; 1999 Feb; 136(1):83-7. PubMed ID: 10211944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
    Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
    Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y
    Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyltransferase polymorphism and risk of colorectal adenoma and cancer: a pooled analysis of variations from 59 studies.
    Liu J; Ding D; Wang X; Chen Y; Li R; Zhang Y; Luo R
    PLoS One; 2012; 7(8):e42797. PubMed ID: 22905173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis.
    Sy SK; de Kock L; Diacon AH; Werely CJ; Xia H; Rosenkranz B; van der Merwe L; Donald PR
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4129-38. PubMed ID: 25963985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
    Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
    Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.